Clinical trial data for all drugs in current use

BMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e7304 (Published 29 October 2012)
Cite this as: BMJ 2012;345:e7304

Related articles

Letter: We need access to data on all clinical trials, not just some

Letter: Additional requirements for complex interventions

Letter: Introducing the HRA’s new system

News: Europe’s drug agency will publish clinical trial data for new products from 2014

News: MPs are to investigate need for drug companies to share clinical trial data

Editorial: The new BMJ policy on sharing data from drug and device trials

Letter: John Bell’s conflict of interest

News: GSK backs BMJ’s new policy to publish only studies with full access to data

Editor's Choice: Open data: seize the moment

Observations: Open letter to Roche about oseltamivir trial data

Feature: Tamiflu: the battle for secret drug data

Feature: Rosiglitazone: what went wrong?

Analysis: Neuraminidase inhibitors—the story behind the Cochrane review

News roundup [abridged versions appear in the paper journal]: Manufacturer admits increase in suicidal behaviour in patients taking paroxetine

See more

Endgames: Treatment allocation in trials: cluster randomisation

Research: Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis

Editorial: PSA screening for prostate cancer

Editorial: Does US health reform reduce hospital readmission rates?

This article has been cited by other articles:

THIS WEEK'S POLL